RS49590B - Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata - Google Patents

Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata

Info

Publication number
RS49590B
RS49590B YUP-566/98A YU56698A RS49590B RS 49590 B RS49590 B RS 49590B YU 56698 A YU56698 A YU 56698A RS 49590 B RS49590 B RS 49590B
Authority
RS
Serbia
Prior art keywords
hydrogen
alkyl
atpase inhibitor
halogen
different
Prior art date
Application number
YUP-566/98A
Other languages
English (en)
Serbian (sr)
Inventor
Christer Cedersberg
George Sachs
Original Assignee
Astrazeneca Ab.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab., filed Critical Astrazeneca Ab.,
Publication of YU56698A publication Critical patent/YU56698A/sh
Publication of RS49590B publication Critical patent/RS49590B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
YUP-566/98A 1996-06-20 1998-12-09 Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata RS49590B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals

Publications (2)

Publication Number Publication Date
YU56698A YU56698A (sh) 2004-12-31
RS49590B true RS49590B (sr) 2007-06-04

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-566/98A RS49590B (sr) 1996-06-20 1998-12-09 Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata

Country Status (27)

Country Link
US (4) US20010008900A1 (enExample)
EP (1) EP0921787B1 (enExample)
JP (1) JP2000512993A (enExample)
CN (1) CN1178648C (enExample)
AT (1) ATE252885T1 (enExample)
AU (1) AU726859B2 (enExample)
BR (1) BR9709838A (enExample)
CA (1) CA2257405A1 (enExample)
CZ (1) CZ298213B6 (enExample)
DE (1) DE69725860T2 (enExample)
DK (1) DK0921787T3 (enExample)
EE (1) EE04606B1 (enExample)
ES (1) ES2208921T3 (enExample)
HU (1) HUP9901794A3 (enExample)
IL (2) IL127542A0 (enExample)
IS (1) IS2216B (enExample)
NO (1) NO323295B1 (enExample)
NZ (1) NZ332990A (enExample)
PL (1) PL189716B1 (enExample)
PT (1) PT921787E (enExample)
RS (1) RS49590B (enExample)
RU (1) RU2203662C2 (enExample)
SE (1) SE9602442D0 (enExample)
SK (1) SK284204B6 (enExample)
TR (1) TR199802647T2 (enExample)
UA (1) UA64715C2 (enExample)
WO (1) WO1997048380A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
JP2002512262A (ja) * 1998-04-30 2002-04-23 セプラコール， インク． Ｒ−レイブプラゾール組成物及び方法
EP1073333A4 (en) * 1998-04-30 2005-06-15 Sepracor Inc S-RABEPRAZOLE COMPOSITIONS AND METHODS
ID28273A (id) 1998-08-10 2001-05-10 Partnership Of Michael E Garst Prodrug inhibitor pompa proton
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
ATE321538T1 (de) 1998-08-12 2006-04-15 Altana Pharma Ag Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) * 1993-04-27 2004-06-29 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
ES2316333T3 (es) * 1994-07-08 2009-04-16 Astrazeneca Ab Forma de dosificacion en tabletas constituida por unidades multiples.
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
DE69725860D1 (de) 2003-12-04
ES2208921T3 (es) 2004-06-16
YU56698A (sh) 2004-12-31
ATE252885T1 (de) 2003-11-15
NO985964L (no) 1999-02-22
CN1222074A (zh) 1999-07-07
CZ298213B6 (cs) 2007-07-25
EE9800435A (et) 1999-06-15
IL127542A0 (en) 1999-10-28
IS4923A (is) 1998-12-15
CN1178648C (zh) 2004-12-08
HUP9901794A2 (hu) 2000-04-28
SE9602442D0 (sv) 1996-06-20
HUP9901794A3 (en) 2002-11-28
TR199802647T2 (xx) 1999-03-22
PL189716B1 (pl) 2005-09-30
HK1018590A1 (en) 1999-12-30
EP0921787A1 (en) 1999-06-16
AU3469097A (en) 1998-01-07
DE69725860T2 (de) 2004-09-09
IS2216B (is) 2007-03-15
JP2000512993A (ja) 2000-10-03
AU726859B2 (en) 2000-11-23
CA2257405A1 (en) 1997-12-24
IL127542A (en) 2006-08-01
SK165598A3 (en) 1999-08-06
EE04606B1 (et) 2006-04-17
NZ332990A (en) 2000-07-28
UA64715C2 (en) 2004-03-15
US20010008900A1 (en) 2001-07-19
PL330910A1 (en) 1999-06-07
WO1997048380A1 (en) 1997-12-24
US20090036494A1 (en) 2009-02-05
DK0921787T3 (da) 2004-02-23
US20050113418A1 (en) 2005-05-26
NO323295B1 (no) 2007-03-05
RU2203662C2 (ru) 2003-05-10
BR9709838A (pt) 1999-08-10
EP0921787B1 (en) 2003-10-29
PT921787E (pt) 2004-03-31
NO985964D0 (no) 1998-12-18
CZ420398A3 (cs) 2000-02-16
US20070276007A1 (en) 2007-11-29
SK284204B6 (sk) 2004-10-05

Similar Documents

Publication Publication Date Title
RS49590B (sr) Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata
JP4818516B2 (ja) 化合物の抗菌剤としての新規な使用
US20030008903A1 (en) R-lansoprazole compositions and methods
US20010025107A1 (en) S-lansoprazole compositions and methods
JP4610086B2 (ja) 改善された化学的方法および医薬処方物
RS56698B1 (sr) Kalup za ubrizgavanje, alat za livenje ubrizgavanjem koji sadrži kalup za ubrizgavanje, postupci njihovih upotreba
US20040171647A1 (en) S(-)rabeprazole compositions and methods
KR20050025635A (ko) (ｓ)-판토프라졸의 염 및 이의 수화물
KR100483092B1 (ko) H+,k+-atp아제억제제의투여방법
JP2003517434A (ja) ヒドロキシオメプラゾール組成物及びその使用
HK1018590B (en) Administration regimen of h+,k+-atpase inhibitors
Udupa Proton Pump Inhibitors–An Overview
US20060142346A1 (en) S-lansoprazole compositions and methods
CN101428017A (zh) 一种含泰诺拉唑的治疗消化性溃疡药物组合物
CN101428022A (zh) 一种含潘妥拉唑的治疗消化性溃疡药物组合物
CN101428023A (zh) 一种治疗消化性溃疡药物组合物
CN101428024A (zh) 一种含拉呋替丁的治疗消化性溃疡药物组合物
CN101428018A (zh) 一种含呋喃唑酮的治疗消化性溃疡药物组合物